Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28188355 | 1.00 | ABCB11 (0.49) | ABCB11KDM4ETDP1CYP3A4ALOX12 | |
| SCHEMBL11338058 | 0.86 | KDM4E (0.58) | ABCB11KDM4ETDP1NR1H4ALDH1A1 | |
| SCHEMBL134715 | 0.84 | KMT2A (0.57) | ABCB11KDM4ETDP1NR1H4ALDH1A1 | |
| SCHEMBL6869400 | 0.82 | ACHE (0.59) | ABCB11KDM4ETDP1NR1H4ALDH1A1 | |
| SCHEMBL21328028 | 0.82 | KMT2A (0.55) | ABCB11KDM4ETDP1NR1H4ALDH1A1 | |
| SCHEMBL21328040 | 0.82 | KMT2A (0.55) | ABCB11KDM4ETDP1NR1H4ALDH1A1 | |
| SCHEMBL21328030 | 0.82 | KMT2A (0.55) | ABCB11KDM4ETDP1NR1H4ALDH1A1 | |
| SCHEMBL21328026 | 0.82 | KMT2A (0.55) | ABCB11KDM4ETDP1NR1H4ALDH1A1 | |
| SCHEMBL28782069 | 0.82 | KMT2A (0.55) | ABCB11KDM4ETDP1NR1H4ALDH1A1 | |
| SCHEMBL17294832 | 0.82 | CYP4F2 (0.62) | ABCB11KDM4ETDP1NR1H4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-59065038-A | — | — | None | — | — | JP | disclosed |
| CN-120121751-A | Method for detecting chlorophenols in waste gas and application thereof | 华电莱州发电有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-114163325-B | Method for synthesizing dicamba by using continuous flow reactor | 江苏优嘉植物保护有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-115054600-B | Aromatic sulfonamide derivatives | 拜耳制药股份公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-111822032-B | Catalyst for synthesizing 2,5-dichlorophenol and in-situ synthesis method of 2,5-dichlorophenol | 江苏扬农化工集团有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-115054600-A | Aromatic sulfonamide derivatives | 拜耳制药股份公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114984003-A | Aromatic sulfonamide derivatives | 拜耳制药股份公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-109415321-B | Aromatic sulfonamide derivatives | 拜耳制药股份公司 | 2022-06-17 | — | — | CN | disclosed |
| US-11274076-B2 | Process for preparing 1, 2-benzenedimethanol compound | GOWAN COMPANY, L.L.C. (US) | 2022-03-15 | — | — | US | disclosed |
| CN-114163325-A | Method for synthesizing dicamba by using continuous flow reactor | 江苏优嘉植物保护有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-20080262070-A1 | Pharmaceutically Active Tetrahydro-Pyrrolizinone Compounds | BAUMANN KARL | 2008-10-23 | — | — | US | disclosed |
| EP-1937685-A1 | TETRAHYDRO-PYRROLIZINONE COMPOUNDS AS LFA-I MEDIATORS | Novartis AG (CH) | 2008-07-02 | — | — | EP | disclosed |
| EP-1935916-A1 | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2008-06-25 | — | — | EP | disclosed |
| EP-1857482-A1 | POLYARYLENE BLOCK COPOLYMER AND USE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2007-11-21 | — | — | EP | disclosed |
| WO-2007039286-A1 | TETRAHYDRO-PYRROLIZINONE COMPOUNDS AS LFA-I MEDIATORS | NOVARTIS AG (CH) | 2007-04-12 | — | — | WO | disclosed |
| EP-0466569-B1 | Process for preparation of N-phenylacetyl derivative of tetrahydrothieno[3,2-c]pyridine and intermediate of synthesis | SANOFI SA (FR) | 1996-04-17 | — | — | EP | disclosed |
| EP-0466569-A1 | Process for preparation of N-phenylacetyl derivative of tetrahydrothieno[3,2-c]pyridine and intermediate of synthesis | SANOFI (FR) | 1992-01-15 | — | — | EP | disclosed |
| JP-S5965038-A | SYNTHESIS OF 3,6-DICHLORO-2-HYDROXYACETOPHENONE | SHIONOGI & CO LTD | 1984-04-13 | — | — | JP | disclosed |
| US-4326882-A | Trichlorophenoxy alkanoic acid free of chlorinated dibenzo-p-dioxins | PPG INDUSTRIES, INC. (US) | 1982-04-27 | — | — | US | disclosed |
| US-4293707-A | Process for preparing trichlorophenoxy alkanoic acid and hydrolyzable derivatives thereof free of chlorinated dibenzo-p-dioxins | PPG INDUSTRIES, INC. (US) | 1981-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262070-A1 | Pharmaceutically Active Tetrahydro-Pyrrolizinone Compounds | VCAM1, ICAM1, EPCAM | ABCB11 1805/4885KDM4E 3500/4885TDP1 1760/4885 |
| US-11274076-B2 | Process for preparing 1, 2-benzenedimethanol compound | ADH1A, ADH1C, CYP2E1 | ABCB11 281/4885KDM4E 3316/4885TDP1 3387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.